missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Matuzumab Chimeric Recombinant Mouse Monoclonal Antibody (Matuzumab)

Description
This antibody binds the extracellular domain III of the human EGFR and does not cross react with murine EGFR. It was also reported that residues S460/G461 in EGFR domain III are essential components of the epitope.
Matuzumab is a humanized monoclonal antibody used in cancer treatment. It has a high affinity for EGFR, frequently associated with the growth of blood vessels in malignancy, facilitating tumor growth and survival.
Specifications
Specifications
| Antigen | Matuzumab Chimeric |
| Applications | ELISA, Flow Cytometry, Inhibition Assays, Western Blot, Immunocytochemistry |
| Classification | Recombinant Monoclonal |
| Clone | Matuzumab |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.02% ProClin 300 |
| Gene Alias | EMD-72000; H425 |
| Host Species | Mouse |
| Immunogen | The parental mouse antibody was generated by immunizing BALB/c mice intraperitoneally with A431 cells in phosphate buffered saline (PBS). Later on the humanzied version of the antibody was created by grafting CDRs of the murine antibody onto human constant regions. |
| Show More |